XML 36 R28.htm IDEA: XBRL DOCUMENT v3.23.3

ADDITIONAL FINANCIAL STATEMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2023

ADDITIONAL FINANCIAL STATEMENT INFORMATION

Schedule of additional financial statement information, balance sheet

Certain balance sheet amounts are comprised of the following (in thousands):

​	​	​	​	​	​	​
​		September 30, 2023			December 31, 2022
Accounts receivable, net:	​	​	​	​	​	​
Oil, natural gas and natural gas liquids revenues	​	$	24,571	​	$	33,980
Joint interest accounts	​	​	1,668	​	​	3,201
Other	​	​	938	​	​	793
​	​	$	27,177	​	$	37,974
Prepaids and other:	​	​	​	​	​	​
Prepaids	​	$	347	​	$	715
Funds in escrow	​	​	344	​	​	341
Other	​	​	95	​	​	75
​	​	$	786	​	$	1,131
Other assets (Non-current):	​	​	​	​	​	​
Investment in unconsolidated affiliate	​	$	1,435	​	$	1,561
Contract asset	​	​	8,050	​	​	—
Funds in escrow	​	​	545	​	​	527
Other	​	​	738	​	​	739
​	​	$	10,768	​	$	2,827
Accounts payable and accrued liabilities:	​	​	​	​	​	​
Trade payables	​	$	16,256	​	$	42,919
Accrued oil and natural gas capital costs	​	​	12,353	​	​	19,911
Revenues and royalties payable	​	​	21,016	​	​	26,759
Accrued employee compensation	​	​	1,548	​	​	2,300
Accrued lease operating expenses	​	​	8,059	​	​	8,005
Other	​	​	185	​	​	201
​	​	$	59,417	​	$	100,095

​

​

​

Investment in Unconsolidated Affiliate. In May 2022, the Company entered into a joint venture with Caracara Services, LLC (“Caracara”) to develop an acid gas treatment facility to remove hydrogen sulfide and carbon dioxide from its produced natural gas. Caracara provided the initial capital for the construction of the treatment facility. The Company contributed certain full cost pool assets to the related party joint venture in a non-cash exchange for a retained 5% equity interest in Wink Amine Treater, LLC (“WAT”) (previously Brazos Amine Treater, LLC (“BAT”), an unconsolidated subsidiary. For accounting purposes, since the Company does not control the key activities (e.g. operating and maintaining the facility) which most significantly impact economic performance nor does the Company have the obligation to absorb losses or the right to receive benefits that could potentially be significant, the Company is not the primary beneficiary of WAT. Accordingly, the Company accounts for its investment in WAT (a related party) using the equity method of accounting based on its ability to exercise significant influence, but not control, over the key activities of the joint venture. For more information related to this joint venture, see Note 9, “Commitments and Contingencies”.

X

- References

No definition available.

+ Details

Name:	batl_AdditionalFinancialInformationDisclosureAbstract
Namespace Prefix:	batl_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for supplemental balance sheet amounts, which may include descriptions and amounts for assets, liabilities, and/or equity.

+ References

No definition available.

+ Details

Name:	batl_ScheduleOfAdditionalFinancialInformationBalanceSheetTableTextBlock
Namespace Prefix:	batl_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration